SARS-CoV-2 neutralising antibody testing in Europe: towards harmonisation of neutralising antibody titres for better use of convalescent plasma and comparability of trial data.
dc.contributor.author | Nguyen, Dung | |
dc.contributor.author | Simmonds, Peter | |
dc.contributor.author | Steenhuis, Maurice | |
dc.contributor.author | Wouters, Elise | |
dc.contributor.author | Desmecht, Daniel | |
dc.contributor.author | Garigliany, Mutien | |
dc.contributor.author | Romano, Marta | |
dc.contributor.author | Barbezange, Cyril | |
dc.contributor.author | Maes, Piet | |
dc.contributor.author | Van Holm, Bram | |
dc.contributor.author | Mendoza, Joaquín | |
dc.contributor.author | Oyonarte, Salvador | |
dc.contributor.author | Fomsgaard, Anders | |
dc.contributor.author | Lassaunière, Ria | |
dc.contributor.author | Zusinaite, Eva | |
dc.contributor.author | Resman Rus, Katarina | |
dc.contributor.author | Avšič-Županc, Tatjana | |
dc.contributor.author | Reimerink, Johan Hj | |
dc.contributor.author | Brouwer, Fiona | |
dc.contributor.author | Hoogerwerf, Marieke | |
dc.contributor.author | Reusken, Chantal Bem | |
dc.contributor.author | Grodeland, Gunnveig | |
dc.contributor.author | Le Cam, Sophie | |
dc.contributor.author | Gallian, Pierre | |
dc.contributor.author | Amroun, Abdennour | |
dc.contributor.author | Brisbarre, Nadège | |
dc.contributor.author | Martinaud, Christophe | |
dc.contributor.author | Leparc Goffart, Isabelle | |
dc.contributor.author | Schrezenmeier, Hubert | |
dc.contributor.author | Feys, Hendrik B | |
dc.contributor.author | van der Schoot, C Ellen | |
dc.contributor.author | Harvala, Heli | |
dc.date.accessioned | 2021-07-15T19:16:57Z | |
dc.date.available | 2021-07-15T19:16:57Z | |
dc.identifier.pmid | 34240697 | |
dc.identifier.doi | 10.2807/1560-7917.ES.2021.26.27.2100568 | |
dc.identifier.uri | http://hdl.handle.net/10029/625076 | |
dc.language.iso | en | en_US |
dc.subject | Europe | en_US |
dc.subject | SARS-CoV-2 | en_US |
dc.subject | convalescent plasma | en_US |
dc.subject | neutralising antibodies | en_US |
dc.subject | standardisation, COVID-19 | en_US |
dc.title | SARS-CoV-2 neutralising antibody testing in Europe: towards harmonisation of neutralising antibody titres for better use of convalescent plasma and comparability of trial data. | en_US |
dc.type | Article | en_US |
dc.identifier.eissn | 1560-7917 | |
dc.identifier.journal | Euro Surveill 2021; 26(27):pii. 2100568 | en_US |
dc.source.journaltitle | Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin | |
dc.source.volume | 26 | |
dc.source.issue | 27 | |
dc.source.country | Sweden |